Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars? ; volume:37 ; number:6 ; day:13 ; month:10 ; year:2023 ; pages:855-871 ; date:11.2023
BioDrugs ; 37, Heft 6 (13.10.2023), 855-871, 11.2023
- Urheber
-
Kirsch-Stefan, Nadine
Guillen, Elena
Ekman, Niklas
Barry, Sean
Knippel, Verena
Killalea, Sheila
Weise, Martina
Wolff-Holz, Elena
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-023-00631-4
- URN
-
urn:nbn:de:101:1-2024010808524058902693
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kirsch-Stefan, Nadine
- Guillen, Elena
- Ekman, Niklas
- Barry, Sean
- Knippel, Verena
- Killalea, Sheila
- Weise, Martina
- Wolff-Holz, Elena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biosimilars – Biosimilars: ja, aber
Biosimilars
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biosimilars : Handbuch
Key elements for planning and conducting shared decision-making implementation trials
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
Ethical decision-making
Judicial Decision-Making
Divine Decision-Making
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
Integrating scientific expertise into regulatory decision-making : national traditions and European innovations
Biosimilars – Biosimilars: ja, aber
Biosimilars
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biosimilars : Handbuch
Key elements for planning and conducting shared decision-making implementation trials
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
Ethical decision-making
Judicial Decision-Making
Divine Decision-Making
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
Integrating scientific expertise into regulatory decision-making : national traditions and European innovations
Biosimilars – Biosimilars: ja, aber
Biosimilars
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biosimilars : Handbuch
Key elements for planning and conducting shared decision-making implementation trials
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
Ethical decision-making
Judicial Decision-Making
Divine Decision-Making
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents